GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug targets Hard-to-Treat cancers in early trial
Disease control TerminatedThis early-phase study tested a new drug called 177Lu-FF58, which delivers radiation directly to cancer cells that have specific markers (integrins). The goal was to check safety, find the right dose, and see if it shrinks tumors in people with advanced pancreatic, stomach, or br…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New imaging agent studied for brain and pancreatic cancers
Diagnosis TerminatedThis study tested a new radioactive imaging agent called [68Ga]-FF58 to see how well it could detect certain solid tumors, including glioblastoma, breast cancer that spread to the brain, gastroesophageal cancer, and pancreatic cancer. The study was early-phase and involved 14 adu…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated May 26, 2026 08:19 UTC